Concepedia

Yoko Franchetti

YF

Statistics

Publications

10

Citations

1K

H-Index

10

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

University of Pittsburgh

Imaging Center

Yoko Franchetti is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2012–2021

10

Publications

10

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 451 citations

, , +10

Minimally Invasive Esophagectomy

James D. Luketich, Arjun Pennathur, Yoko Franchetti et al. · Annals of Surgery · 2015 · 209 citations · Full text

, , +17

Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities

Mariella G. Filbin, Sukriti K. Dabral, Maria F. Pazyra‐Murphy et al. · Nature Medicine · 2013 · 150 citations · Full text

, , +16

Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis

Jason R. Stubbs, Margaret Stedman, Sai Liu et al. · Clinical Journal of the American Society of Nephrology · 2019 · 67 citations · Full text

, , +14

10% Tumor Diameter Shrinkage on the First Follow-Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitors: A Follow-Up Validation Study

Katherine M. Krajewski, Yoko Franchetti, Mizuki Nishino et al. · The Oncologist · 2014 · 49 citations · Full text

, , +17

1–5 of 10